FBDS
Fuss Brands Corp.
Key Financials
Net Income
$-2755404
↓ 445.4%
Revenue
$0
N/A
Gross Profit
$43.2M
↑ 46.8%
Operating Income
$-2750359
↓ 446.7%
Total Liabilities
$915502.00
↑ 55.7%
EPS (Diluted)
$-0.14
↓ 366.7%
Total Assets
$228180.00
↑ 63.7%
Shareholders' Equity
$-687322.00
↓ 53.2%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 9/11/2025 | View on SEC |
| 8-K | 8/25/2025 | View on SEC |
| 10-Q | 6/9/2025 | View on SEC |
| 10-Q | 3/5/2025 | View on SEC |
| 10-K | 2/11/2025 | View on SEC |
| NT 10-K | 1/28/2025 | View on SEC |
| 10-Q | 9/6/2024 | View on SEC |
| 10-Q | 6/27/2024 | View on SEC |
| NT 10-Q | 6/13/2024 | View on SEC |
| 8-K | 5/8/2024 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | FBDS |
| Company Name | Fuss Brands Corp. |
| CIK | 926844 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1031 |
| State of Incorporation | NV |
| Phone | 917-720-3366 |